Tonix Pharmaceuticals获得罗格斯大学授予的选择性Sigma-1受体拮抗剂Tnx-4900的许可,用于慢性神经性疼痛

美股速递
Dec 16

Tonix Pharmaceuticals获得罗格斯大学授予的选择性Sigma-1受体拮抗剂Tnx-4900的许可,用于慢性神经性疼痛

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10